<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
SRNE
Sorrento Therapeutics
$
()


  • Three new option listings on April 15th

    4/15/2024 - 08:31am
  • Scilex files emergency motion with bankruptcy court for production of records

    10/27/2023 - 14:09pm
  • Sorrento reports consummation of sale of shares held in Scilex

    9/22/2023 - 11:42am
  • Scilex reports consummation of purchase of shares owned by Sorrento

    9/22/2023 - 07:48am
  • Sorrento Therapeutics announces Phase 2a trial results for resiniferatoxin

    9/7/2023 - 09:14am
  • Sorrento announces auction for sale of Scilex securities

    8/8/2023 - 09:54am
  • Sorrento Therapeutics issues FAQ in response to request from Scilex holders

    7/27/2023 - 09:09am
  • Scilex reports June net sales $4.2M-$5.2M vs. $3.3M last year

    7/5/2023 - 09:19am
  • Sorrento Therapeutics announces Phase IIa sudy results of abivertinib

    7/5/2023 - 09:06am
  • Sorrento announces full enrollment of Phase 3 trial with olgotrelvir

    6/26/2023 - 09:14am
  • Sorrento Therapeutics announces $4.6M government contract from NIAID

    6/13/2023 - 09:18am
  • Shanghai Escugen Biotechnology announces results from FIH study of ESG401

    6/5/2023 - 09:09am
dynamic_feed Breaking News